These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38758194)

  • 1. Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth with Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Trial.
    Gruber N; Wittenberg A; Brener A; Abiri S; Mazor-Aronovitch K; Yackobovitch-Gavan M; Averbuch S; Ben Ari T; Levek N; Levran N; Landau Z; Rachmiel M; Pinhas-Hamiel O; Lebenthal Y
    Diabetes Technol Ther; 2024 May; ():. PubMed ID: 38758194
    [No Abstract]   [Full Text] [Related]  

  • 2. MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life Experience.
    Rachmiel M; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Jacobi-Polishook T; Ben Ari T; Abiri S; Landau Z; Pinhas-Hamiel O
    Diabetes Technol Ther; 2023 Sep; 25(9):643-651. PubMed ID: 37219952
    [No Abstract]   [Full Text] [Related]  

  • 3. The Advanced Hybrid Closed Loop Improves Glycemia Risk Index, Continuous Glucose Monitoring Index, and Time in Range in Children with Type 1 Diabetes: Real-World Data from a Single Center Study.
    Eviz E; Yesiltepe Mutlu G; Karakus KE; Can E; Gokce T; Muradoglu S; Hatun S
    Diabetes Technol Ther; 2023 Oct; 25(10):689-696. PubMed ID: 37449922
    [No Abstract]   [Full Text] [Related]  

  • 4. A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.
    Jendle J; Buompensiere MI; Ozdemir Saltik AZ; de Portu S; Smith-Palmer J; Pollock RF; Cohen O
    Diabetes Technol Ther; 2023 Dec; 25(12):864-876. PubMed ID: 37801658
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI).
    Petrovski G; Al Khalaf F; Campbell J; Day E; Almajaly D; Hussain K; Pasha M; Umer F; Hamdan M; Khalifa A
    BMC Endocr Disord; 2022 Mar; 22(1):80. PubMed ID: 35351095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control.
    Lombardo F; Passanisi S; Alibrandi A; Bombaci B; Bonfanti R; Delvecchio M; Di Candia F; Mozzillo E; Piccinno E; Piona CA; Rigamonti A; Scialabba F; Maffeis C; Salzano G
    Diabetes Technol Ther; 2023 Jun; 25(6):404-413. PubMed ID: 36763343
    [No Abstract]   [Full Text] [Related]  

  • 7. The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatment.
    Quirós C; Alonso-Carril N; Rodríguez-Rodríguez S; Barahona MJ; Orois A; Simó-Servat A; Ramos M; Perea V
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Feb; 70(2):130-135. PubMed ID: 36925230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor.
    Cordero TL; Dai Z; Arrieta A; Niu F; Vella M; Shin J; Rhinehart AS; McVean J; Lee SW; Slover RH; Forlenza GP; Shulman DI; Pop-Busui R; Thrasher JR; Kipnes MS; Christiansen MP; Buckingham BA; Pihoker C; Sherr JL; Kaiserman KB; Vigersky RA
    Diabetes Technol Ther; 2023 Sep; 25(9):652-658. PubMed ID: 37252734
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed‑loop system: A randomized controlled trial.
    Elbarbary NS; Ismail EAR
    Diabetes Res Clin Pract; 2022 Sep; 191():110045. PubMed ID: 35987309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms.
    Nattero-Chávez L; Lecumberri Pascual E; De La Calle E; Bayona Cebada A; Ruiz T; Quintero Tobar A; Lorenzo M; Sánchez C; Izquierdo A; Luque-Ramírez M; Escobar-Morreale HF
    Diabetes Res Clin Pract; 2023 May; 199():110627. PubMed ID: 36940793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.
    Benhalima K; Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C
    Lancet Diabetes Endocrinol; 2024 Jun; 12(6):390-403. PubMed ID: 38697182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are all HCL systems the same? long term outcomes of three HCL systems in children with type 1 diabetes: real-life registry-based study.
    Santova A; Plachy L; Neuman V; Pavlikova M; Petruzelkova L; Konecna P; Venhacova P; Skvor J; Pomahacova R; Neumann D; Vosahlo J; Strnadel J; Kocourkova K; Obermannova B; Pruhova S; Cinek O; Sumnik Z
    Front Endocrinol (Lausanne); 2023; 14():1283181. PubMed ID: 37908748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetes.
    Jalilova A; Pilan BŞ; Demir G; Özbaran B; Balkı HG; Arslan E; Köse SG; Özen S; Darcan Ş; Gökşen D
    Eur J Pediatr; 2024 Jul; 183(7):3095-3103. PubMed ID: 38661816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes with MiniMed
    Abraham MB; Smith GJ; Dart J; Davis EA; Jones TW
    Diabetes Technol Ther; 2024 May; 26(5):341-345. PubMed ID: 38215208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12-Month Real-Life Efficacy of the MiniMed 780G Advanced Closed-Loop System in Patients Living with Type 1 Diabetes: A French Observational, Retrospective, Multicentric Study.
    Lablanche S; Delagenière J; Jalbert M; Sonnet E; Benichou M; Arnold N; Spiteri A; Le Berre JP; Renard E; Chevalier N; Borot S; Bonnemaison E; Coffin C; Teissier MP; Benhamou PY; Borel JC; Penfornis A; Joubert M; Kessler L
    Diabetes Technol Ther; 2024 Jun; 26(6):426-432. PubMed ID: 38236643
    [No Abstract]   [Full Text] [Related]  

  • 16. Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control.
    Lepore G; Rossini A; Bellante R; Corsi A; Scaranna C; Dodesini AR; Trevisan R
    Acta Diabetol; 2022 Oct; 59(10):1309-1315. PubMed ID: 35857108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes.
    Bassi M; Patti L; Silvestrini I; Strati MF; Ponzano M; Minuto N; Maggi D
    Front Endocrinol (Lausanne); 2023; 14():1099024. PubMed ID: 36777356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring.
    van den Heuvel T; Kolassa R; Keuthage W; Kroeger J; Ré R; de Portu S; Vorrink L; Shin J; Castañeda J; Vigersky R; Cohen O
    J Diabetes Sci Technol; 2024 Sep; 18(5):1132-1138. PubMed ID: 36949671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Between the Glycemia Risk Index and Longitudinal Hemoglobin A1c in Children and Young Adults With Type 1 Diabetes.
    Panfil K; Redel JM; Vandervelden CA; Lockee B; Kahkoska AR; Tallon EM; Williams DD; Clements MA
    J Diabetes Sci Technol; 2024 Jul; 18(4):771-778. PubMed ID: 38715286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of Selected Psychological Parameters and Quality of Life of Patients With Type 1 Diabetes Mellitus Undergoing Transition From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to the MiniMed 780G Advanced Hybrid Closed-Loop System: Post hoc Analysis of a Randomized Control Study.
    Cyranka K; Matejko B; Juza A; Kieć-Wilk B; Krzyżowska S; Cohen O; Da Silva J; Lushchyk M; Malecki MT; Klupa T
    JMIR Form Res; 2023 Jan; 7():e43535. PubMed ID: 36692945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.